RPG Investment Advisory’s Novartis NVS Stock Holding History

RPG Investment Advisory’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-70	Closed	-$6K	–	370
2020 Q3	$6K	Hold	70	–	–	﹤0.01%	223
2020 Q2	$6K	Hold	70	–	–	﹤0.01%	229
2020 Q1	$6K	Hold	70	–	–	﹤0.01%	198
2019 Q4	$7K	Hold	70	–	–	﹤0.01%	200
2019 Q3	$6K	Hold	70	–	–	﹤0.01%	202
2019 Q2	$6K	Sell	70 -8	-10%	-$677	﹤0.01%	207
2019 Q1	$7K	Hold	78	–	–	﹤0.01%	216
2018 Q4	$6K	Hold	78	–	–	﹤0.01%	218
2018 Q3	$6K	Hold	78	–	–	﹤0.01%	243
2018 Q2	$5K	Buy	+78	New	+$5.38K	﹤0.01%	258
2018 Q1	–	Sell	-20	Closed	-$2K	–	435
2017 Q4	$2K	Hold	20	–	–	﹤0.01%	409
2017 Q3	$2K	Buy	+20	New	+$1.51K	﹤0.01%	323

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

RPG Investment Advisory's NVS Position: Q4 2020 in Review

RPG Investment Advisory sold out of Novartis (NVS) in Q4 2020, closing a stake of 70 shares — an estimated $6K sold.

RPG Investment Advisory first reported a position in NVS in Q3 2017 and held it in 12 quarters. The position peaked at $7K in Q4 2019. 1,176 funds tracked by Wall St. Rank hold NVS as of Q4 2020.

RPG Investment Advisory reported no remaining Novartis position as of Q4 2020 after selling out during the quarter.
RPG Investment Advisory sold 70 Novartis shares in Q4 2020, an estimated $6K.
RPG Investment Advisory first reported a position in Novartis in Q3 2017 and held it in 12 quarters.
RPG Investment Advisory's Novartis position peaked at $7K in Q4 2019.
1,176 funds tracked by Wall St. Rank held Novartis as of Q4 2020.

Based on RPG Investment Advisory's 13F filing for Q4 2020, filed 27 Jan 2021.